Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Myelodysplastic-Myeloproliferative Diseases × Disulfides × 90 days × Clear all

Sponsor

Conditions

Lung Neoplasms 14 Carcinoma, Non-Small-Cell Lung 11 Ovarian Neoplasms 5 Fallopian Tube Neoplasms 5 Colorectal Neoplasms 4 Carcinoma, Renal Cell 4 Urinary Bladder Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Pancreatic Neoplasms 3 Nasopharyngeal Carcinoma 3 Carcinoma, Hepatocellular 3 Carcinoma 3 Urogenital Neoplasms 2 Urethral Neoplasms 2 Ureteral Neoplasms 2 Oropharyngeal Neoplasms 2 Neoplasm Metastasis 2 Mouth Neoplasms 2 Melanoma 2 Lymphoid Interstitial Pneumonia 2 Laryngeal Neoplasms 2 Hypopharyngeal Neoplasms 2 Colitis 2 Brenner Tumor 2 Brain Neoplasms 2 Adenocarcinoma, Mucinous 2 Triple Negative Breast Neoplasms 1 Tongue Neoplasms 1 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1

Interventions

Specimen Handling 7 Biopsy 6 fludarabine 3 ruxolitinib 2 decitabine and cedazuridine drug combination 2 Tacrolimus 2 Injections 2 Decitabine 2 Cyclophosphamide 2 Busulfan 2 Azacitidine 2 venetoclax 1 veliparib 1 tagraxofusp 1 posaconazole 1 peginterferon alfa-2b 1 onvansertib 1 merphos 1 iadademstat 1 fludarabine phosphate 1 fedratinib 1 axatilimab 1 Topotecan 1 Thiotepa 1 Succimer 1 Stem Cell Transplantation 1 Pentetic Acid 1 Mycophenolic Acid 1 Methotrexate 1 Melphalan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡